UCI – Das Tumorzentrum Bern - Navigation
{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Seghers, S., Mand\u00f3, P., Eid, M., Tan, C. J., Jayraj, A., Jatwani, K., Faisal, M. S., Luong, V., Young, J. A., Teuwen, L.-A., Prenen, H., \u0026 Segelov, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/206090\u0022\u003EAssessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022\u003C\/a\u003E. \u003Ci\u003EJCO Oncology Practice\u003C\/i\u003E, \u003Ci\u003E21\u003C\/i\u003E, 1335-1343.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Michael, M., Wong, R., Gill, S., Strickland, A. H., Pavlakis, N., Shapiro, J. D., Link, E., Farrell, M., Ngan, S. Y., Tie, J., Heriot, A. G., Goldstein, D., Mitchell, C., Roth, S., Wilson, K., Mui, M., Ramsay, R. G., \u0026 Segelov, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/212009\u0022\u003EThe Ave-Rec trial: Phase II trial of PDL1\/PD-1 blockade with Avelumab post Chemoradiotherapy for locally advanced resectable T3B-4\/N1-2 Rectal cancer\u003C\/a\u003E. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E, 3452-3462.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Body, A., Lal, L., Downie, P., Anazodo, A., O\u2019Brien, T., Padhye, B., Fuentes-Bolanos, N., Srihari, S., Stephanie Ahern, E., Haber, M., Smith, C., Lineburg, K., Turville, S., Naing, Z., Rawlinson, W., Buttery, J., Raina MacIntyre, C., Milch, V., \u0026 Segelov, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/214668\u0022\u003EImmune Response to COVID-19 Vaccination in Children With Cancer\u003C\/a\u003E. \u003Ci\u003EPediatrics\u003C\/i\u003E.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Bivens, K. M., Guyon, A. J. A. A., Behan, V., \u0026 Segelov, E. (2025). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/212503\u0022\u003EAn approach to implementing patient and public involvement in investigator-initiated clinical trials.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E155\u003C\/i\u003E, 4563.","year":2025,"type":"Journal Article (Review)"},{"title":"Xi, X., Liu, L., Tuano, N., Tailhades, J., Mouradov, D., Steen, J., Sieber, O., Cryle, M., Nguyen-Dumont, T., Segelov, E., \u0026 Rosenbluh, J. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/209774\u0022\u003ESRP19 and the protein secretion machinery is a targetable vulnerability in cancers with APC loss\u003C\/a\u003E. \u003Ci\u003EProceedings of the National Academy of Sciences\u003C\/i\u003E, \u003Ci\u003E122\u003C\/i\u003E(15), e2409677122.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T.-Y., van Hagen, T., Wei, P.-L., Day, F., Mehta, S., \u2026 Toh, H. C. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/203531\u0022\u003EAspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet Gastroenterology \u0026 Hepatology\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(3), 198-209.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Body, A., Lal, L., Srihari, S., MacIntyre, C. R., Buttery, J., Ahern, E. S., Opat, S., Leahy, M. F., Hamad, N., Milch, V., Turville, S., Smith, C., Lineburg, K., Naing, Z., Rawlinson, W., \u0026 Segelov, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194550\u0022\u003EComprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer\u003C\/a\u003E. \u003Ci\u003EVaccine\u003C\/i\u003E, \u003Ci\u003E46\u003C\/i\u003E, 126547.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Teuwen, L.-A., Young, J., Alessy, S., \u00d6zdemir, B., Martina, D., Folorunso, S., Bourlon, M. T., Prenen, H., \u0026 Segelov, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/188716\u0022\u003EIntersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022\u003C\/a\u003E. \u003Ci\u003EJCO Global Oncology\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E, e2400238.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Teuwen, L.-A., Ahmad, Z., \u0026 Segelov, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179651\u0022\u003ETime to Update-Requesting Inclusive Submission Categories for Oncology Research\u003C\/a\u003E. \u003Ci\u003EJCO Global Oncology\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E, e2400136.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Wang, H., Grech, L., Wong, J., Hoffman, D., de Courten, B., Sillars, B., Savage, M., Kwok, A., Nguyen, M., Bain, N., Day, D., \u0026 Segelov, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178476\u0022\u003ECOVID-19 Vaccine Acceptance, Hesitancy, and Uptake in People with Diabetes in Australia\u003C\/a\u003E. \u003Ci\u003EVaccines\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(6).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Tan, S., Nelson, A. J., Muthalaly, R. G., Ramkumar, S., Hamilton, J., Nerlekar, N., Segelov, E., \u0026 Nicholls, S. J. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178164\u0022\u003ECardiovascular Risk in Cancer Patients Treated with Immune Checkpoint Inhibitors: Challenges and Future Directions\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Preventive Cardiology\u003C\/i\u003E.","year":2024,"type":"Journal Article (Original Article)"},{"title":"McPhee, N. J., Leach, M., Nightingale, C. E., Harris, S. J., Segelov, E., \u0026 Ristevski, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/176831\u0022\u003EDifferences in cancer clinical trial activity and trial characteristics at metropolitan and rural trial sites in Victoria, Australia\u003C\/a\u003E. \u003Ci\u003EThe Australian Journal of Rural Health\u003C\/i\u003E, \u003Ci\u003E32\u003C\/i\u003E(3), 569-581.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Tan, S., Spear, E., Sane, N., Chan, J., Nelson, A. J., Alamgeer, M., Nerlekar, N., Segelov, E., \u0026 Nicholls, S. J. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171988\u0022\u003EAtherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study\u003C\/a\u003E. \u003Ci\u003EHeart, Lung \u0026 Circulation\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(5), 721-729.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Anaka, M., Chan, D., Pattison, S., Thawer, A., Franco, B., Moody, L., Jackson, C., Segelov, E., \u0026 Singh, S. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171743\u0022\u003EPatient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments\u003C\/a\u003E. \u003Ci\u003EThe Oncologist\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(3), 227-234.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Blennerhassett, R., Hamad, N., Grech, L., Kwok, A., Choi, T., Forsyth, C., Jagger, J., Opat, S., Harris, S., Chan, B. A., Nguyen, M., Bain, N., Day, D., \u0026 Segelov, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/205410\u0022\u003EAttitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies\u003C\/a\u003E. \u003Ci\u003EActa Haematologica\u003C\/i\u003E, \u003Ci\u003E147\u003C\/i\u003E(5), 543-554.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Day, D., Starus, A., Gebski, V., Simes, J., Hayes, T., Padinharakam, S., Strickland, A., Briscoe, K., Varma, S., Barnet, M., Jackson, C., Horvath, L., Price, T., Tebbutt, N., Karki, B., Diakos, C., Chia, J., Toh, H., Jones, F., \u0026 Segelov, E. (2023, October). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171070\u0022\u003E586P Minimal residual disease (MRD) detection using a tumour na\u00efve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial\u003C\/a\u003E. In \u003Ci\u003EAnnals of oncology\u003C\/i\u003E (Vols. 34, Issue Suppl 2, pp. S426-S427). ESMO Congress 2023. Oxford University Press.","year":2023,"type":"Conference Paper (Abstract)"},{"title":"Zhu, H., Hao, S., Tseng, I., Shen, J., Rivin Del Campo, E., Davies, A., Segelov, E., Liu, Q., Chen, Y., Song, S., \u0026 Zhao, K. (2023). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170000\u0022\u003EInterim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EQuantitative Imaging in Medicine and Surgery\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(9), 6280-6295.","year":2023,"type":"Journal Article (Review)"},{"title":"Martina, D., \u0026 Segelov, E. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/168172\u0022\u003EImproving Equity Across Cancer Care Continuum in Asia Pacific\u003C\/a\u003E. \u003Ci\u003EJCO Global Oncology\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(e2300056), e2300056.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Day, D., Toh, H. C., Ali, R., Foo, E. M. J., Simes, J., Chia, J. W. K., \u0026 Segelov, E. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/168171\u0022\u003EOperational Challenges of an Asia-Pacific Academic Oncology Clinical Trial\u003C\/a\u003E. \u003Ci\u003EJCO Global Oncology\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(e2300040), e2300040.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Grech, L., Kwok, A., Nguyen, M., Winkel, A., Butler, E., Allan, M., Bain, N., \u0026 Segelov, E. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164586\u0022\u003ECOVID-19 Vaccine Status, Intent, Hesitancy, and Disease-Related Beliefs in People with Multiple Sclerosis\u003C\/a\u003E. \u003Ci\u003EVaccines\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(2), 410.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Choi, T., Chan, B., Grech, L., Kwok, A., Webber, K., Wong, J., Nguyen, M., Bain, N., Day, D., McCartney, A., Hamer, R., \u0026 Segelov, E. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164587\u0022\u003EFactors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model\u003C\/a\u003E. \u003Ci\u003EVaccines\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(2), 239.","year":2023,"type":"Journal Article (Original Article)"}]}
